Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
Tashkent Pediatric Medical Institute, Tashkent (Uzbekistan)
5 More presentations in this session
Doctor S. Mukhtarova (Tashkent, UZ)
Mrs E. Santos (Vila Nova de Gaia, PT)
Miss E. Santos (Vila Nova de Gaia, PT)
Doctor K. Franz (Berlin, DE)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
You may be interested in
Congress Presentation
